Doorgaan naar hoofdnavigatie
Doorgaan naar zoeken
Ga verder naar hoofdinhoud
Prinses Máxima Centrum Voorpagina
Nederlands
English
Content zoeken bij Prinses Máxima Centrum
Voorpagina
Profielen
Onderzoeksgroepen
Uitrusting
Onderzoeksoutput
Prijzen
Activiteiten
Knipsels
Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients
Simone De Vries
, Michael Schaapveld
, Cécile P.M. Janus
, Laurien A. Daniëls
, Eefke J. Petersen
, Richard W.M. Van Der Maazen
, Josée M. Zijlstra
, Max Beijert
, Marten R. Nijziel
, Karijn M.S. Verschueren
,
Leontien C.M. Kremer
, Anna M. Van Eggermond
, Pieternella J. Lugtenburg
, Augustinus D.G. Krol
, Judith M. Roesink
, Wouter J. Plattel
, Dick Johan Van Spronsen
, Gustaaf W. Van Imhoff
, Jan Paul De Boer
, Berthe M.P. Aleman
Flora E. Van Leeuwen
Toon overzicht 1 andere
Toon minder
Group Kremer
Onderzoeksoutput
:
Bijdrage aan tijdschrift
›
Artikel
›
peer review
82
Citaten (Scopus)
Overzicht
Vingerafdruk
Vingerafdruk
Duik in de onderzoeksthema's van 'Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients'. Samen vormen ze een unieke vingerafdruk.
Sorteer per
Gewicht
Alfabetische volgorde
Keyphrases
By Stages
10%
Calendar Period
10%
Cardiovascular Mortality
10%
Cause-specific
10%
Cause-specific Mortality
100%
Chemotherapy
40%
Chemotherapy Alone
10%
Competing Risks
10%
Confidence Interval
60%
Cumulative Mortality
20%
Excess Mortality
40%
Hazard Ratio
10%
High Risk
10%
Hodgkin Lymphoma
100%
Hodgkin Lymphoma Survivors
20%
Infection-related Mortality
10%
Irradiation
10%
Life Expectancy
10%
Long-term Toxicity
10%
Lymphoma Patients
100%
Lymphoma Relapse
10%
Multicenter Cohort
10%
Older Individuals
10%
Optimal Selection
10%
Patient Selection
10%
Primary Chemotherapy
10%
Radiotherapy
30%
Radiotherapy Alone
10%
Risk of Death
10%
Solid Tumors
10%
Spleen
10%
Splenectomy
10%
Standardized Mortality Ratio
20%
Subdistribution Hazard Ratio
10%
Survivors
10%
Treatment Impact
10%
Treatment-related Morbidity
10%
Immunology and Microbiology
Infectious Disease
33%
Life Expectancy
33%
Mortality
100%
Population
66%
Standardized Mortality Ratio
66%
Medicine and Dentistry
Cardiovascular Disease
8%
Chemotherapy
50%
Hazard Ratio
16%
Hodgkin's Lymphoma
100%
Infection
8%
Life Expectancy
8%
Mortality
25%
Population
16%
Radiation Therapy
33%
Solid Malignant Neoplasm
8%
Splenectomy
8%
Standardized Mortality Ratio
16%
Nursing and Health Professions
Cardiovascular Disease
8%
Confidence Interval
50%
Hazard Ratio
16%
Hodgkin Disease
100%
Infection
8%
Life Expectancy
8%
Mortality
25%
Population
16%
Radiotherapy
33%
Solid Malignant Neoplasm
8%
Splenectomy
8%
Standardized Mortality Ratio
16%
Pharmacology, Toxicology and Pharmaceutical Science
Cardiovascular Disease
8%
Chemotherapy
50%
Hodgkin Disease
100%
Infection
8%
Life Expectancy
8%
Mortality
25%
Solid Malignant Neoplasm
8%
Standardized Mortality Ratio
16%
Psychology
Infectious Disease
50%